We are live on ! Find out more
RPID icon

Rapid Micro Biosystems

42 hedge funds and large institutions have $42.5M invested in Rapid Micro Biosystems in 2025 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

650% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 2

57% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 7

45% more funds holding

Funds holding: 2942 (+13)

0.63% less ownership

Funds ownership: 37.34%36.71% (-0.63%)

14% less capital invested

Capital invested by funds: $49.5M → $42.5M (-$7.02M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
42
Holders Change
+13
Holders Change %
+44.83%
% of All Funds
0.51%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
15
Increased
11
Reduced
7
Closed
2
Calls
Puts
Net Calls
Net Calls Change

RPID Hedge Fund Activity: Q4 2025 in Review

42 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in Rapid Micro Biosystems (RPID) for Q4 2025, worth a combined $42.5M — down 14% from $49.5M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new RPID positions and 2 closed out — a net gain of 13 holders — while 11 added to existing stakes and 7 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $439K. The largest seller was Parkman Healthcare Partners, cutting an estimated $1.94M.

  • 42 institutional investors held Rapid Micro Biosystems (RPID) as of Q4 2025, up from 29 in Q3 2025.
  • Funds reported $42.5M of Rapid Micro Biosystems stock for Q4 2025, down 14% quarter-over-quarter.
  • 15 funds opened new Rapid Micro Biosystems positions in Q4 2025 and 2 closed out, a net change of +13 holders.
  • The largest Rapid Micro Biosystems buyer in Q4 2025 was Citadel Advisors, an estimated $439K added.
  • The largest Rapid Micro Biosystems seller in Q4 2025 was Parkman Healthcare Partners, an estimated $1.94M sold.

Based on aggregated 13F filings for Q4 2025.